Research and Awards > Research Projects > Featured Project

Featured Project

Matt Reed Researcher

Research and Running for CHSS

One of the thousands of runners in the Virgin London Marathon earlier this year was Dr Matt Reed from Edinburgh. He was not only raising vital funds for us,  nearly £3000 in total,  but he is also one of our research partners from the Royal Infirmary of Edinburgh.  “I had always wanted to run the London Marathon and I was delighted to run and raise money for CHSS. The charity’s focus of chest, heart and stroke illness are conditions which I see every day of my working life and the work that CHSS do to improve the quality of life for people affected by these conditions is hugely important.”


Dr Reed is a Consultant and Honorary Reader in Emergency Medicine and Deputy Director of the Emergency Medicine Research Group Edinburgh (EMERGE). He is currently Chief Investigator on two CHSS funded studies. The first is looking at an ambulatory ECG monitor (Zio® XT monitor) in Emergency Department syncope (blackout) patients (the PATCH-ED study). The monitor is stuck onto a patient’s chest wall in the Emergency Department and can be worn continuously to record the patient’s ECG for up to 14 days. The study has just reported its findings at the European Heart Rhythm Association Congress. The study showed that the patch ECG monitor picked up more than 5 times as many important abnormal heart rhythms that were associated with symptoms than standard care, and was able to diagnose the underlying cause for syncope (blackout) in 74% of patients. Patients were very satisfied with the patch and 91% of patients agreed or strongly agreed that the patch was easy to use with 72% agreeing or strongly agreeing that the patch was comfortable to wear.The second CHSS funded study is investigating the utility of a smart phone based event recorder (AliveCor) in patients presenting with palpitations and pre-syncope to the Emergency Department (the IPED study). This study, a 10 centre UK hospital randomised trial has finished recruiting its 243 patients and is presently in the data analysis stage with results due out later in the year. Commenting on the studies, Dr Reed said, “We are towards the end of these studies and without CHSS we would have been unable to even start this type of ground breaking work and we are looking forward to being able to make sure the benefits of our work can help people across Scotland in the future.”